SABCS 2023: As Conference Ends, Experts Look to the Future
“What will you do Monday morning?” was the question posed by the final session on the final full day...
“What will you do Monday morning?” was the question posed by the final session on the final full day...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
Breast cancer recurrence rates were similar for postmenopausal women with estrogen receptor-positive DCIS whether they took anastrozole or tamoxifen,...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway...
A major question that researchers are trying to answer is: What links obesity with cancer development and adverse survival?
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.
The Black TNBC Sanctuary is a resource that provides key information and resources specifically for Black patients with TNBC.
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...
Guest Post by Sammantha McDonald Past participant in the AACR’s Scientist↔Survivor Program (SSP)
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors' Picks, a monthly...
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
As the temperature soared this summer, the laps around the park became harder to endure. When her skin chafed...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
This quarter’s new tools and strategies for cancer research included molecular jackhammers and biobots that crawl.
Notice of Termination and Rescheduling The American Association for Cancer Research (AACR) has made the difficult decision, after careful...
Please note: All times are US Eastern Standard Time (EST) Monday January 11, 2021 Tuesday, January 12, 2021 MONDAY,...